Top Qs
Timeline
Chat
Perspective
Carteolol
Chemical compound From Wikipedia, the free encyclopedia
Remove ads
Carteolol is a non-selective beta blocker used to treat glaucoma. It is administered in the form of eye drops.[citation needed]
Carteolol was patented in 1972 and approved for medical use in 1980.[1]
Remove ads
Pharmacology
Pharmacodynamics
Carteolol is a beta blocker, or an antagonist of the β-adrenergic receptors.[2] It is selective for the β1-adrenergic receptor and has intrinsic sympathomimetic activity.[2] Carteolol has also been found to act as a serotonin 5-HT1A and 5-HT1B receptor antagonist in addition to being a beta blocker.[3]
Pharmacokinetics
Carteolol is classified as a beta blocker with low lipophilicity and hence lower potential for crossing the blood–brain barrier.[2] This in turn may result in fewer effects in the central nervous system as well as a lower risk of neuropsychiatric side effects.[2]
Remove ads
Chemistry
The experimental log P of carteolol is 1.1 and its predicted log P ranges from 0.99 to 2.39.[4][5][6][7] It is a hydrophilic or low-lipophilicity beta blocker.[7][2]
Society and culture
Brand names
Brand names of carteolol include Arteolol, Arteoptic, Calte, Cartéabak, Carteol, Cartéol, Cartrol, Elebloc, Endak, Glauteolol, Mikelan, Ocupress, Poenglaucol, Singlauc, and Teoptic.
References
Further reading
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads